KLK3 and Familial prostate cancer: This study evaluated the feasibility of detecting circulating tumor cells (CTCs) in localized high risk (HR) and biochemically recurrent (BCR) prostate cancer (PCa) patients and examined the correlation between CTCs, serum prostate specific antigen (PSA) levels, 18F-DCFPyL PET parameters and clinical progression.